{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:36:47Z","timestamp":1790707007377,"version":"4.1.0"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:title>ABSTRACT:<\/jats:title><jats:p>Seizure disorders frequently are diagnosed and managed during adolescence; therefore, obstetrician\u2013gynecologists who care for adolescents should be familiar with epilepsy and other seizure disorders, as well as antiepileptic drugs. Patients diagnosed with seizure disorders during childhood may have increased seizure activity with puberty and menarche due to the neuroactive properties of endogenous steroid hormones. Compared with patients without epilepsy, patients with epilepsy are more likely to experience anovulatory cycles, irregular menstrual bleeding, and amenorrhea. Although hormonal suppression should not be initiated before puberty or menarche, prepubertal counseling may be appropriate, and obstetrician\u2013gynecologists may work with young patients and their families to develop a plan to initiate with menarche. Additionally, obstetrician\u2013gynecologists should be aware of any medication changes, including antiepileptics, for adolescent patients with seizure disorders. Research on hormonal therapy for the treatment of epilepsy is scant; however, the anticonvulsant properties of various progestins have been explored as potential treatment. There is no conclusive evidence that combination hormonal contraception increases epileptic seizures, and epilepsy itself poses no increased risk of an adverse outcome for those using combined oral contraceptive pills, the contraceptive patch, or a contraceptive ring. Because many antiepileptic drugs are teratogenic, discussing sexual health with and providing effective contraceptive choices to this population is critical. Obstetrician\u2013gynecologists should work with patients with seizure disorders to develop a plan when pregnancy occurs.<\/jats:p>","DOI":"10.1097\/aog.0000000000003827","type":"journal-article","created":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T05:54:48Z","timestamp":1587794088000},"page":"e213-e220","source":"Crossref","is-referenced-by-count":21,"title":["Gynecologic Management of Adolescents and Young Women With Seizure Disorders"],"prefix":"10.1097","volume":"135","member":"276","reference":[{"key":"R1-20230711","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ijgo.2016.03.015","article-title":"Neurologist knowledge about interactions between antiepileptic drugs and contraceptive methods","volume":"134","author":"Suto","year":"2016","journal-title":"Int J Gynaecol Obstet"},{"key":"R2-20230711","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1212\/WNL.0000000000003509","article-title":"Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies [published erratum appears in Neurology 2017;89:642]","volume":"88","author":"Fiest","year":"2017","journal-title":"Neurology"},{"key":"R3-20230711","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.eplepsyres.2010.05.003","article-title":"Seizure exacerbation and hormonal cycles in women with epilepsy","volume":"90","author":"Kim","year":"2010","journal-title":"Epilepsy Res"},{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2147\/IJWH.S28872","article-title":"Diagnosis and management of catamenial seizures: a review","volume":"4","author":"Verrotti","year":"2012","journal-title":"Int J Womens Health"},{"key":"R5-20230711","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1528-1167.2010.02897.x","article-title":"Antiepileptic drugs, sex hormones, and PCOS","volume":"52","author":"Verrotti","year":"2011","journal-title":"Epilepsia"},{"key":"R6-20230711","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1528-1157.1995.tb01009.x","article-title":"Ovulatory function in epilepsy","volume":"36","author":"Cummings","year":"1995","journal-title":"Epilepsia"},{"key":"R7-20230711","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.seizure.2015.02.012","article-title":"Interactions between hormones and epilepsy","volume":"28","author":"Tauboll","year":"2015","journal-title":"Seizure"},{"key":"R8-20230711","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/ana.21411","article-title":"Hyperandrogenism, ovulatory dysfunction, and polycystic ovary syndrome with valproate versus lamotrigine","volume":"64","author":"Morrell","year":"2008","journal-title":"Ann Neurol"},{"key":"R9-20230711","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.biopsych.2005.10.017","article-title":"Valproate is associated with new-onset oligoamenorrhea with hyperandrogenism in women with bipolar disorder","volume":"59","author":"Joffe","year":"2006","journal-title":"Biol Psychiatry"},{"key":"R10-20230711","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jpag.2012.05.011","article-title":"Gynecologic and reproductive health concerns of adolescents using selected psychotropic medications","volume":"26","author":"Talib","year":"2013","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R11-20230711","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.seizure.2007.11.014","article-title":"Catamenial epilepsy: definition, prevalence pathophysiology and treatment","volume":"17","author":"Herzog","year":"2008","journal-title":"Seizure"},{"key":"R12-20230711","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S1474-4422(12)70239-9","article-title":"Neuroendocrine considerations in the treatment of men and women with epilepsy [published erratum appears in Lancet Neurol 2013;12:128]","volume":"12","author":"Harden","year":"2013","journal-title":"Lancet Neurol"},{"key":"R13-20230711","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.seizure.2015.02.024","article-title":"Catamenial epilepsy: update on prevalence, pathophysiology and treatment from the findings of the NIH Progesterone Treatment Trial","volume":"28","author":"Herzog","year":"2015","journal-title":"Seizure"},{"key":"R14-20230711","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1212\/WNL.9.5.352","article-title":"The role of estrogens in catamenial exacerbation of epilepsy","volume":"9","author":"Logothetis","year":"1959","journal-title":"Neurology"},{"key":"R15-20230711","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1212\/WNL.36.12.1607","article-title":"Intermittent progesterone therapy and frequency of complex partial seizures in women with menstrual disorders","volume":"36","author":"Herzog","year":"1986","journal-title":"Neurology"},{"key":"R16-20230711","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1212\/WNL.45.9.1660","article-title":"Progesterone therapy in women with complex partial and secondary generalized seizures","volume":"45","author":"Herzog","year":"1995","journal-title":"Neurology"},{"key":"R17-20230711","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1212\/WNL.0b013e318259e1f9","article-title":"Progesterone vs placebo therapy for women with epilepsy: a randomized clinical trial. Progesterone Trial Study Group","volume":"78","author":"Herzog","year":"2012","journal-title":"Neurology"},{"key":"R18-20230711","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1212\/WNL.34.9.1255","article-title":"Treatment of seizures with medroxyprogesterone acetate: preliminary report","volume":"34","author":"Mattson","year":"1984","journal-title":"Neurology"},{"key":"R19-20230711","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0022-3476(73)80529-3","article-title":"Medroxprogesterone acetate in the treatment of seizures associated with menstruation","volume":"83","author":"Zimmerman","year":"1973","journal-title":"J Pediatr"},{"key":"R20-20230711","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.seizure.2015.02.011","article-title":"Differential impact of antiepileptic drugs on the effects of contraceptive methods on seizures: interim findings of the epilepsy birth control registry","volume":"28","author":"Herzog","year":"2015","journal-title":"Seizure"},{"key":"R21-20230711","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/AOG.0000000000000387","article-title":"Menstrual and reproductive issues in adolescents with physical and developmental disabilities","volume":"124","author":"Quint","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R22-20230711","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/BF00810354","article-title":"The effect of a synthetic GnRH analogue on catamenial epilepsy: a study in ten patients","volume":"239","author":"Bauer","year":"1992","journal-title":"J Neurol"},{"key":"R23-20230711","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/0140-6736(91)92354-5","article-title":"Catamenial epilepsy and goserelin","volume":"338","author":"Haider","year":"1991","journal-title":"Lancet"},{"key":"R24-20230711","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/epi.14608","article-title":"Cannabis-based products for pediatric epilepsy: a systematic review","volume":"60","author":"Elliott","year":"2019","journal-title":"Epilepsia"},{"key":"R25-20230711","doi-asserted-by":"crossref","first-page":"k2827","DOI":"10.1136\/bmj.k2827","article-title":"FDA approves its first cannabis based medicine","volume":"361","author":"Wise","year":"2018","journal-title":"BMJ"},{"key":"R26-20230711","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1212\/WNL.0000000000006425","article-title":"Quality improvement in neurology: Epilepsy Quality Measurement Set 2017 update","volume":"91","author":"Patel","year":"2018","journal-title":"Neurology"},{"key":"R27-20230711","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.yebeh.2009.01.024","article-title":"Antiepileptic drugs: are women aware of interactions with oral contraceptives and potential teratogenicity?","volume":"14","author":"Pack","year":"2009","journal-title":"Epilepsy Behav"},{"key":"R28-20230711","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.contraception.2008.02.002","article-title":"Reproductive history, sexual behavior and use of contraception in women with epilepsy","volume":"77","author":"Davis","year":"2008","journal-title":"Contraception"},{"key":"R29-20230711","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.contraception.2011.04.017","article-title":"Co-prescription of antiepileptic drugs and contraceptives","volume":"85","author":"Wang","year":"2012","journal-title":"Contraception"},{"key":"R30-20230711","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.yebeh.2006.09.013","article-title":"Epilepsy and women's health issues: unmet needs\u2014survey results from women with epilepsy","volume":"10","author":"Vazquez","year":"2007","journal-title":"Epilepsy Behav"},{"key":"R31-20230711","first-page":"697","article-title":"Pregnancy, epilepsy, and women's issues","volume":"19","author":"Pennell","year":"2013","journal-title":"Continuum (Minneap Minn)"},{"key":"R32-20230711","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/epi.13320","article-title":"Contraceptive practices of women with epilepsy: findings of the epilepsy birth control registry","volume":"57","author":"Herzog","year":"2016","journal-title":"Epilepsia"},{"key":"R33-20230711","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1528-1157.1979.tb04834.x","article-title":"Do anticonvulsants reduce the efficacy of oral contraceptives?","volume":"20","author":"Coulam","year":"1979","journal-title":"Epilepsia"},{"key":"R34-20230711","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/bmj.321.7262.674","article-title":"Population based, prospective study of the care of women with epilepsy in pregnancy","volume":"321","author":"Fairgrieve","year":"2000","journal-title":"BMJ"},{"key":"R35-20230711","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0074-7742(08)00006-8","article-title":"Contraception in women with epilepsy: pharmacokinetic interactions, contraceptive options, and management","volume":"83","author":"Dutton","year":"2008","journal-title":"Int Rev Neurobiol"},{"issue":"12 suppl 4","key":"R36-20230711","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1212\/WNL.67.12_suppl_4.S56","article-title":"Optimizing therapy of seizures in women who use oral contraceptives","volume":"67","author":"Harden","year":"2006","journal-title":"Neurology"},{"issue":"RR-3","key":"R37-20230711","first-page":"1","article-title":"U.S. medical eligibility criteria for contraceptive use, 2016","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"R38-20230711","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.seizure.2015.03.006","article-title":"Interactions between hormonal contraception and antiepileptic drugs: clinical and mechanistic considerations","volume":"28","author":"Reimers","year":"2015","journal-title":"Seizure"},{"key":"R39-20230711","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.contraception.2010.06.013","article-title":"The use of hormonal contraception among women taking anticonvulsant therapy","volume":"83","author":"Gaffield","year":"2011","journal-title":"Contraception"},{"key":"R40-20230711","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1046\/j.1528-1157.2003.55602.x","article-title":"Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjects","volume":"44","author":"Doose","year":"2003","journal-title":"Epilepsia"},{"key":"R41-20230711","first-page":"e128","article-title":"Use of hormonal contraception in women with coexisting medical conditions. ACOG Practice Bulletin No. 206. American College of Obstetricians and Gynecologists [published erratum appears in Obstet Gynecol 2019;133:1288]","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"key":"R42-20230711","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/AOG.0b013e31820095a2","article-title":"Effectiveness of oral contraceptive pills in a large U.S. cohort comparing progestogen and regimen","volume":"117","author":"Dinger","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R43-20230711","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.seizure.2007.11.013","article-title":"Which contraception for women with epilepsy?","volume":"17","author":"Schwenkhagen","year":"2008","journal-title":"Seizure"},{"key":"R44-20230711","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0920-1211(01)00305-9","article-title":"Lamotrigine plasma levels reduced by oral contraceptives","volume":"47","author":"Sabers","year":"2001","journal-title":"Epilepsy Res"},{"key":"R45-20230711","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1111\/j.1528-1167.2005.10105.x","article-title":"Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations","volume":"46","author":"Reimers","year":"2005","journal-title":"Epilepsia"},{"key":"R46-20230711","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2147\/OAJC.S85541","article-title":"Contraception for women with epilepsy: counseling, choices, and concerns","volume":"7","author":"Reimers","year":"2016","journal-title":"Open Access J Contracept"},{"key":"R47-20230711","first-page":"414","article-title":"Depot medroxyprogesterone acetate contraception in women with medical problems","volume":"41","author":"Frederiksen","year":"1996","journal-title":"J Reprod Med"},{"key":"R48-20230711","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1097\/AOG.0000000000001585","article-title":"Menstrual manipulation for adolescents with physical and developmental disabilities. Committee Opinion No. 668. American College of Obstetricians and Gynecologists","volume":"128","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R49-20230711","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1097\/AOG.0000000000002632","article-title":"Adolescents and long-acting reversible contraception: implants and intrauterine devices. ACOG Committee Opinion No. 735. American College of Obstetricians and Gynecologists","volume":"131","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R50-20230711","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1783\/147118902101195992","article-title":"Observational series on women using the contraceptive Mirena concurrently with anti-epileptic and other enzyme-inducing drugs","volume":"28","author":"Bounds","year":"2002","journal-title":"J Fam Plann Reprod Health Care"},{"key":"R51-20230711","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.contraception.2017.03.004","article-title":"The effect of carbamazepine on etonogestrel concentrations in contraceptive implant users","volume":"95","author":"Lazorwitz","year":"2017","journal-title":"Contraception"},{"key":"R52-20230711","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1111\/epi.13893","article-title":"Impaired bone and muscle development in young people treated with antiepileptic drugs","volume":"58","author":"Simm","year":"2017","journal-title":"Epilepsia"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000003827","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T18:12:06Z","timestamp":1722795126000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000003827"}},"subtitle":["ACOG Committee Opinion, Number 806"],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000003827","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]}}}